APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
申请人:AbbVie Inc.
公开号:US20150299197A1
公开(公告)日:2015-10-22
Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds.
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
申请人:AbbVie Inc.
公开号:US10081628B2
公开(公告)日:2018-09-25
Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds. One embodiment of such compounds is 4-(4-[2-(4-chloro-2-fluorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-(3-nitro-4-[(tetrahydro-2H-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide.
[EN] APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES<br/>[FR] AGENTS INDUISANT L'APOPTOSE POUR LE TRAITEMENT DU CANCER ET DE MALADIES IMMUNES ET AUTO-IMMUNES
申请人:ABBVIE INC
公开号:WO2014158528A1
公开(公告)日:2014-10-02
Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds.
Sugawara, Fumio; Nakayama, Haruhiko; Stroebel, Gary A., Agricultural and Biological Chemistry, 1986, vol. 50, # 9, p. 2261 - 2272
作者:Sugawara, Fumio、Nakayama, Haruhiko、Stroebel, Gary A.、Ogawa, Tomoya